openPR Logo
Press release

Digital PCR and Quantitative PCR Market Trends and Growth Propellers 2024

08-08-2017 03:47 PM CET | Health & Medicine

Press release from: TMR - Research Reports

Digital PCR and Quantitative PCR Market Trends and Growth

Polymerase chain reaction (PCR) technology is used to amplify or make several copies of deoxyribonucleic acid (DNA) sequence of interest. Polymerase chain reaction (PCR) technology is used in various applications ranging from DNA cloning, diagnosis of hereditary diseases, functional analysis of genes, paternity testing, detection of infectious diseases, and forensic sciences. Digital PCR (dPCR) and quantitative PCR (qPCR) are two major types of polymerase chain reaction (PCR) technologies. Digital PCR is a relatively new technique for DNA amplification and quantification that uses molecular counting protocol. Digital PCR is primarily used to differentiate expression of alleles, track viral infection to individual bacterial cells, quantify cancer genes, and detect fetal DNA in circulating blood. The key advantage of dPCR is that it is insensitive to reaction efficiency, and does not require preparation of standard curves. Real-time PCR, also known as quantitative PCR (qPCR), calculates PCR amplification simultaneously as the reaction proceeds. qPCR does not require post amplification processing, which reduces the turnaround time of the analytical process and the risk of contamination of amplified DNA or RNA.

Read the Comprehensive Overview of Digital PCR (dPCR) and Quantitative PCR (qPCR) Market: http://www.transparencymarketresearch.com/digital-pcr-quantitative-pcr-market.html

Increasing incidence of infectious diseases and genetic disorders and rise in number of diagnostic centers and hospitals are the major factors expected to drive the global digital PCR (dPCR) and qPCR market from 2016 to 2024. In addition, rising public-private investments to spread awareness about disease diagnostics and technologically advanced product launches are accelerating the growth of the global digital PCR (dPCR) and qPCR market. However, high cost of instruments associated with dPCR and limitations in the dPCR and qPCR techniques are expected to hamper the growth of the global digital PCR (dPCR) and qPCR market during the forecast period.

The digital PCR (dPCR) and qPCR market has been segmented based on product, application, end-user, and geography. In terms of product, the market has been segmented into instruments, consumables, and services. Based on application, the market has been segmented into clinical diagnostic, research, and forensic. In terms of end-user, the global market has been segmented into clinical laboratories, pharmaceutical companies, clinical research organization, and academic research institutes.

Geographically, the global digital PCR (dPCR) and quantitative PCR (qPCR) market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounts for a significant share of the global digital PCR (dPCR) and quantitative PCR (qPCR) market due to extensive research and development activities by major pharmaceutical companies in the region. Presence of health care organizations, promising government initiatives in implementing better molecular diagnostic methods in diseases diagnosis, and constantly improving reimbursement scenario for diagnostics is anticipated to propel the global market from 2016 to 2024. Europe is expected to be the second largest market for dPCR and qPCR. The advent of automated PCR instruments, high awareness about latest health care technologies, higher purchasing power, and affordability are likely to boost the dPCR and qPCR market in Europe. Moreover, rising geriatric population is projected to boost market growth in the region. Major factors expected to drive the market in Asia Pacific include improving health care infrastructure and rising private and public investment in life sciences research coupled with technological advancements in countries such as China and India. Significant economic development leading to increased research and development expenditure, and consequently higher usage of PCR in disease diagnosis are also expected to propel market growth in the region. Countries in Latin America such as Mexico and Brazil are expected to be potential markets due to evolving medical diagnostics infrastructure and high health care expenditures.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=17423

Major players operating in this market include Affymetrix, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., RainDance Technologies, Inc., Thermo Fisher Scientific, Inc., JN Medsys, Formulatrix, Inc., and Sigma-Aldrich Co. LLC. (part of Merck).

About TMR

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Digital PCR and Quantitative PCR Market Trends and Growth Propellers 2024 here

News-ID: 660499 • Views: …

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during…
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the…
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to…
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment…

All 5 Releases


More Releases for PCR

PCR & Real-time PCR Molecular Diagnostics Market Size to Expand Lucratively duri …
PCR & Real-time PCR Molecular Diagnostics Market: Introduction Transparency Market Research has published a new report titled, 'Global PCR & Real-time PCR Molecular Diagnostics Market'. According to the report, the global PCR & real-time PCR molecular diagnostics market was valued over US$ 4.1 Bn in 2019. It is projected to expand at a CAGR of ~4% from 2020 to 2030. Polymerase chain reaction (PCR) is used to amplify or make copies…
04-23-2021 | Health & Medicine
Fact.MR
PCR and Real-time PCR Molecular Diagnostics Market – Outlook, Size, Share & Fo …
As per data from the World Health Organization, millions of deaths can be attributed to diseases such as cancer and HIV each year. Further, the recent outbreak of the COVID-19 virus has also created massive demand for effective diagnostics processes. The PCR and real-time PCR molecular diagnostics market has been gaining traction in recent years on the back of investments by PCR diagnostic test manufacturers towards the incorporation of molecular…
Global Real-time PCR (RT-PCR) Fluorescence Probe Market Growth 2020-2025
GLOBAL INFO RESEARCH has lately published a new report titled, *Global and China Real-time PCR (RT-PCR) Fluorescence Probe Market 2020 by Company, Type and Application, Forecast to 2025*. The researchers have offered a broad understanding of the industry with the help of research methodologies such as PESTLE Analysis and Porter's Five Forces. Click to view the full report TOC, figure and tables:  https://www.globalinforesearch.com/Global-Real-time-PCR-(RT-PCR)-Fluorescence-Probe_p418256.html At the start, the report lays emphasis on the key…
PCR Technologiess Market 2027 By Companies(Abbott, F. Hoffmann-La Roche Ltd., Th …
The exclusive report on PCR Technologies Market research report has been formulated with the help of extensive primary research (inputs from industry experts, companies, and stakeholders) and secondary research to get a universal view of the market. The report gives an in-detailed information across global regions, including North America, Europe, Asia Pacific (APAC), Middle East & Africa (MEA), and South America & Central America (SCAM). We follow an iterative research…
Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Intelligence Report Offers …
Polymerase chain reaction (PCR) technology is used to amplify or make several copies of deoxyribonucleic acid (DNA) sequence of interest. Polymerase chain reaction (PCR) technology is used in various applications ranging from DNA cloning, diagnosis of hereditary diseases, functional analysis of genes, paternity testing, detection of infectious diseases, and forensic sciences. Digital PCR (dPCR) and quantitative PCR (qPCR) are two major types of polymerase chain reaction (PCR) technologies. Digital PCR…
United States Digital PCR and Real-time PCR (qPCR) Market Report 2017
24 Market Reports provides a complete data analysis of United States Digital PCR and Real-time PCR (qPCR) Market Report 2017 with Market value, Sales, Price, Industry Analysis and Forecast with the help of Industry Experts. In this report, the United States Digital PCR and Real-time PCR (qPCR) market is expected to reach high by the end of 2022. Geographically, this report splits the United States market into seven regions: • The West • Southwest • The Middle Atlantic • New…